Sandra M. Wang

发表

Steady state kinetics of spleen tyrosine kinase investigated by a real time fluorescence assay.

D. Swinney, D. Shaw, J. Barnett, 2007, Biochemistry.

Molecular Mechanism of the Syk Activation Switch*

Emily K. Tsang, J. M. Bradshaw, A. M. Giannetti, 2008, Journal of Biological Chemistry.

Therapeutic Discovery ErbB 3 Inhibitory Surrobodies Inhibit Tumor Cell Proliferation In Vitro and In Vivo

C. Hannum, R. R. Bhatt, Medini Gore, 2012 .

The crystal structure of JNK2 reveals conformational flexibility in the MAP kinase insert and indicates its involvement in the regulation of catalytic activity.

A. Kuglstatter, D. Shaw, S. Tsing, 2008, Journal of molecular biology.

ErbB3 Inhibitory Surrobodies Inhibit Tumor Cell Proliferation In Vitro and In Vivo

C. Hannum, R. R. Bhatt, Medini Gore, 2012, Molecular Cancer Therapeutics.

3-Amido pyrrolopyrazine JAK kinase inhibitors: development of a JAK3 vs JAK1 selective inhibitor and evaluation in cellular and in vivo models.

Alam Jahangir, Johannes C. Hermann, Seth Harris, 2013, Journal of medicinal chemistry.

Biochemical characterization of the inhibition of the dengue virus RNA polymerase by beta-d-2'-ethynyl-7-deaza-adenosine triphosphate.

D. Swinney, A. Kutach, D. Shaw, 2010, Antiviral research.

Structural Insights for Design of Potent Spleen Tyrosine Kinase Inhibitors from Crystallographic Analysis of Three Inhibitor Complexes

A. Kuglstatter, D. Shaw, J. Barnett, 2009, Chemical biology & drug design.

The crystal structure of JNK2 reveals conformational flexibility in the MAP kinase insert and indicates its involvement in the regulation of catalytic activity.

A. Kuglstatter, D. Shaw, S. Tsing, 2008, Journal of molecular biology.